Publications

La recherche au service
de nos patients

Nos activités de recherche ont permis aux chercheurs de l’ICAP de présenter les résultats de leurs travaux dans des revues référencés au niveau national mais aussi international.

Vous trouverez ci-dessous les principales publications des dernières années.

PUBLICATIONS INDEXÉES DANS PUBMED

  1. Koopman, M ; Garcia-Carbonero, R ; Pinto, C ; Mitroshkin, A ; Bodoky, G ; Mineur, L & al , Continuum of care and survival in patients with metastatic colorectal cancer: results of the real-world prospective, longitudinal cohort PROMETCO study., ESMO Gastrointest Oncol, 2025, 9, 100214

  2. Gandini, A ; Gallois, C ; Blons, H ; Mulot, C ; Agueeff, N ; Lepage, C & al, Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a post hoc analysis of 2973 patients from two adjuvant randomized trials., ESMO Gastrointest Oncol, 2025, 7, 100106

  3. Biau, J ; Sun, X ; Liem, X ; Faivre, JC ; Eker, E ; Blanchard, P & al, Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial., JAMA Netw Open, 2025, 8, e2549975

  4. Ravoire, M ; Vazquez, L , Double metastatic cancer with lung and urothelial carcinoma responding to enfortumab vedotin: a case report and review of the literature., J Med Case Rep, 2025, 20, 50

  5. Martz, N ; Faivre, JC ; Beldjoudi, G ; Arnaud, A ; Chamois, J ; Supiot, S & al, Radiotherapy of bone metastases: 2025 update., Cancer Radiother, 2025, 29, 104769

  6. Khalifa, J ; El Houat, Y ; Thureau, S ; Darréon, J ; Antoni, D ; Blais, E & al, Radiotherapy for primary lung cancer: 2025 update., Cancer Radiother, 2025, 29, 104779

  7. Engels, C ; Marliac Schweitzer, S ; Blond, O ; Boulahssass, R ; David, C ; Faure, H & al , Effects of occupational therapy on quality of life, occupational performance, and occupational satisfaction in older adults with cancer: a multicentre, pragmatic, randomized, controlled trial protocol (OCEAN- OT)., BMC Geriatr, 2025, 25, 1064

  8. Pourel, N ; Parent, L ; Faivre, JC ; Pellen, E ; Lorchel, F ; Brusadin, G , Quality and safety in radiation oncology: Innovation and beyond., Cancer Radiother, 2025, 29, 104766

  9. Pujol, P ; Roca, L ; Lortholary, A ; Lasset, C ; Crivelli, L ; Berthet, P & al, Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)., Eur J Cancer, 2025, 231, 116101

  10. Levy, A ; Tonneau, M ; Darréon, J ; Khalifa, J ; Antoni, D ; Blais, E & al, Radiotherapy for lung metastases., Cancer Radiother, 2025, 29, 104760

  11. Eber, J ; Bockel, S ; Antoni, D ; Khamphan, C ; Noël, G ; Le Fèvre, C, Delineation of organs at risk in radiotherapy and perspectives., Cancer Radiother, 2025, 29, 104758

  12. Hammel, P ; Metges, JP ; Macarulla Mercade, T ; Garcia-Carbonero, R ; Bouché, O ; Portales, F & al , TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second- Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma., J Clin Oncol, 2025, 43, 3714-3727

  13. Chouaid, C ; Giraud, P ; Wislez, M ; Pichon, E ; Stancu, A ; Debieuvre, D & al, Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practice., Respir Med Res, 2025, 88, 101216

  14. Villalba, M ; Gitenay, D ; Zemiti, S ; Rossi, JF ; Campos-Mora, M , Is the MAPK ERK5 the nexus from FAO to NK cell-mediated metastasis immune surveillance?, Front Immunol, 2025, 16, 1641865

  15. Le Fur, E ; Pallandre, M ; Pêtre, A ; Clavère, P ; Quéro, L ; Rio, E & al , Radiotherapy of skin cancers., Cancer Radiother, 2025, 29, 104724

  16. Tougeron, D ; Mineur, L ; Zaanan, A ; Kadi, M ; Poisson Ligeza, C ; Bourgeois, V & al , Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (PRODIGE 62-FFCD 1701-OESIRI)., Eur J Cancer, 2025, 228, 115741

  17. Le Douget, JE ; Jacob, P ; Lepage, C ; Gallois, C ; Sroussi, M ; De Reynies, A & al , Deep Learning on Histologic Slides Accurately Predicts Consensus Molecular Subtypes and Spatial Heterogeneity in Colon Cancer., Mod Pathol, 2025, 38, 100877

  18. Joly, F ; Leary, A ; Ray-Coquard, I ; Asselain, B ; Rodrigues, M ; Gladieff, L & al , Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial., Nat Commun, 2025, 16, 7950

  19. Cayuela, H ; Roques, S ; Arnaud, A ; Germain, C ; Béchet, A ; Champagnon, J, Migration shapes senescence in a long-lived bird., Proc Natl Acad Sci U S A, 2025, 122, e2422882122

  20. Laas, E ; Hamy, AS ; Bachelot, T ; Gougis, P ; Lemonnier, J ; André, F & al, Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial., Clin Pharmacol Ther, 2025, 118, 1192-1201

  21. Cravereau, O ; Bourbonne, V ; Vaugier, L ; Lucia, F ; Tinier, FL ; Cadranel, J & al , AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury., Clin Lung Cancer, 2025, 26, 527-540

  22. Cravéreau, O ; Bourbonne, V ; Vaugier, L ; Lucia, F ; Le Tinier, F ; Cadranel, J & al, [Recommendations on the prevention and management of radiation- induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique]., Cancer Radiother, 2025, 29, 104687

  23. Brain, E ; Mir, O ; Bourbouloux, E ; Rigal, O ; Ferrero, JM ; Kirscher, S & al, Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial., Lancet, 2025, 406, 489-500

  24. Bocha, D ; Le Guevelou, J ; Ortholan, C ; Calderon, B ; Pointreau, Y, Hypofractionated radiotherapy for head and neck squamous cell carcinoma., Cancer Radiother, 2025, 29, 104681

  25. Voyant, C ; Julian, D ; Muraro, S ; Bodez, V ; Pinpin, M ; Leschi, D & al, Improving Clinical Decision-Making in Radiotherapy: A Comparative Analysis of Linear-Quadratic LQ and Linear-Quadratic-Linear LQL Dose Models., Clin Oncol (R Coll Radiol), 2025, 45, 103893

  26. Bergen, ES ; Canton, C ; Boulin, M ; Le Malicot, K ; Bennouna, J ; Gonzalez, D & al, Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients – A post-hoc analysis of the PETACC 8 trial., Eur J Cancer, 2025, 227, 115643

  27. Blanc, JF ; Bouattour, M ; Gauthier, L ; Deshayes, E ; Guillemard, S ; Touchefeu, Y & al , Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study., Oncologist, 2025, 30

  28. Lapeyre, M ; Pointreau, Y ; Alfonsi, M ; Boisselier, P ; Biau, J ; Blanchard, P & al , A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancers., Clin Transl Radiat Oncol, 2025, 53, 100980

  29. Dancoisne, C ; Scotté, F ; Capodano, G ; Carbonnelle, G ; Caunes-Hilary, N ; Chaustier, H & al , Supportive care structures and fundings in French Comprehensive Cancer Centers: a national survey., Support Care Cancer, 2025, 33, 520

  30. Tougeron, D ; Louvet, C ; Desramé, J ; Evesque, L ; Angelergues, A ; Carnot, A & al , Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma., Commun Med (Lond), 2025, 5, 136

  31. Saint-Ghislain, M ; Chabaud, S ; Dalenc, F ; Allouache, D ; Cameron, D ; Martinez, M & al , Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial., ESMO Open, 2025, 10, 105050

  32. Ribeiro-Guerra, M ; Dondon, MG ; Eon-Marchais, S ; Le Gal, D ; Beauvallet, J; Mebirouk, N & al , Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes., Cancers (Basel), 2025, 17,

  33. Gobbini, E ; Diallo, MH ; Pasquier, D ; Schneider, S ; Chouaid, C ; Debieuvre, D & al , Clinical characteristics and management of long survivors in extensive stage small cell lung cancer., Lung Cancer, 2025, 202, 108499

  34. Lecomte, T ; Giraudeau, B ; Phelip, JM ; Tournigand, C ; Ducreux, M ; Tougeron, D & al , Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)., Dig Liver Dis, 2025, 57, 624-630

  35. Vera, P ; Giraud, P ; Hapdey, S ; Gouel, P ; Jan, O ; Le Roux, P & al, Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer., J Nucl Med, 2025, 66, 516-524

  36. Wislez, M ; Mascaux, C ; Cadranel, J ; Thomas, QD ; Ricordel, C ; Swalduz, A & al , Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study., Eur J Cancer, 2025, 219, 115301

  37. Arnaud, A ; Grenier, J ; Boustany, R ; Kirscher, S ; Mege, A ; de Rauglaudre, G & al , Retraction Note: Role of supportive care in improving the quality of life and reducing unscheduled hospital care in patients with metastatic breast cancer., Support Care Cancer, 2025, 33, 156

  38. Randrian, V ; Portales, F ; Bouché, O ; Thezenas, S ; Chibaudel, B ; Mabro, M & al , The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors., J Neurooncol, 2025, 172, 229-238

  39. Poumeaud, F ; Valentin, T ; Fares, N ; Segier, B ; Watson, S ; Verret, B & al , Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy., Eur J Cancer, 2025, 216, 115196

  40. Grassi, P ; Hilgers, W ; Boissier, R ; Bertucci, A ; Bruyat, D ; Duffaud, F & al , A French Multicenter Real-Life Study on the Biological and Clinical Parameters Associated With Response to Immune Checkpoint Inhibitors (ICIs) in Second- Line Treatment of Advanced Urothelial Carcinoma: Impact of Antibiotics Administration at the Time of ICIs Initiation., Clin Genitourin Cancer, 2025, 23, 102283

  41. Dabout, V ; Mineur, L ; Tougeron, D ; Malicot, KL ; Gallois, C ; Phelip, JM & al, Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study., Clin Res Hepatol Gastroenterol, 2025, 49, 102514

  42. Joly, F ; Bazan, F ; Garbay, D ; Ouldbey, Y ; Follana, P ; Champeaux-Orange, É & al , Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)., JNCI Cancer Spectr, 2025, 9

  43. Baron, D ; Pace Loscos, T ; Schiappa, R ; Barbet, N ; Dost, E ; Ben Dhia, S & al , A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial., Ann Oncol, 2025, 36, 208-215

  44. Harter, P ; Marth, C ; Mouret-Reynier, MA ; Cropet, C ; Lorusso, D ; Guerra- Alía, EM & al, Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial., Ann Oncol, 2025, 36, 185-196

  45. Collard, MK ; Mineur, L ; Nekrouf, C ; Denost, Q ; Rouanet, P ; de Chaisemartin, C & al , Final Results of the GRECCAR-6 Trial on Waiting Period Following Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: 5 Years of Follow-up., Dis Colon Rectum, 2025, 68, 199-208

  46. Barthélémy, P ; Thibault, C ; Fléchon, A ; Gross-Goupil, M ; Voog, E ; Eymard, JC & al , Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment., Eur Urol Oncol, 2025, 8, 407-416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contact

Tél. : 04 90 27 61 61

Médecin de recherche clinique

Dr Rania BOUSTANY

Cadres de recherche clinique

Mme Léa RETOURNARD
Mme Céleste DAVID

Infirmière de l’Unité de Recherche Clinique

Tél. : 04 90 27 62 12

Essais en cours

Base des essais

Registre des essais

Répertoire Régional

Un répertoire régional regroupant l’ensemble des essais en cancérologie ouverts dans les établissements de santé de Paca, de Corse et en Principauté de Monaco est également disponible sur le site d’ONCOPACA Corse.
Sa particularité est d’avoir été élaboré et être régulièrement mis à jour en coopération directe avec les promoteurs des essais